Literature DB >> 1178166

Disk space infections in children.

H C Boston, A J Bianco, K H Rhodes.   

Abstract

The present review of disk space infection in children agrees with that carried out in 1962.12 The physician who encounters a child with back or hip pain, irritability, and a change in walking pattern should always suspect an infection of the vertebral column, particularly in the presence of limited spine motion, spasm, and an elevated sedimentation rate. S. aureus still is the usual primary infecting agent. Treatment consisting of rigid immobilization of the spinal column during the acutely painful phase appears to be adequate therapy. The use of antibiotics is not generally recommended. Because of this, hospitalization is usually not prolonged unneccessarily. The rationable for the use of antibiotics in one atypical case included recurrence of clinical signs and symptoms despite immobilization. These included persistent pain and spasm associated with a high sedimentation rate. Disk space aspiration probably is no longer necessary or desirable in the usual patient in whom immobilization is generally effective. The prognosis for most patients is good. Occasionally spinal fusion should be considered in this young age group if mechanical backache persists after the infection has been cured. The findings and recommendations regarding management of this disease in children should not be applied to the adult.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1178166

Source DB:  PubMed          Journal:  Orthop Clin North Am        ISSN: 0030-5898            Impact factor:   2.472


  3 in total

1.  Common bacterial infections in infancy and childhood. 5. Infections of the skeletal system.

Authors:  G A Ahronheim
Journal:  Drugs       Date:  1978-09       Impact factor: 9.546

Review 2.  Kingella kingae intervertebral disk infection.

Authors:  J Amir; P G Shockelford
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

3.  Discitis--the irritable back of childhood.

Authors:  T M O'Brien; F McManus
Journal:  Ir J Med Sci       Date:  1983-11       Impact factor: 1.568

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.